首页> 外文期刊>Clinical and experimental hypertension: CEH >Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids
【24h】

Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids

机译:衰老的小鹿罩大鼠的高血压和肾脏疾病的进展是由肾素-血管紧张素系统的增强影响以及一氧化氮系统和环氧类二十烷酸类药物的抑制介导的

获取原文
获取原文并翻译 | 示例
           

摘要

The fawn-hooded hypertensive (FHH) rat serves as a genetic model of spontaneous hypertension associated with glomerular hyperfiltration and proteinuria. However, the knowledge of the natural course of hypertension and kidney disease in FHH rats remains fragmentary and the underlying pathophysiological mechanisms are unclear. In this study, over the animals' lifetime, we followed the survival rate, blood pressure (telemetry), indices of kidney damage, the activity of renin-angiotensin (RAS) and nitric oxide (NO) systems, and CYP450-epoxygenase products (EETs). Compared to normotensive controls, no elevation of plasma and renal RAS was observed in prehypertensive and hypertensive FHH rats; however, RAS inhibition significantly reduced systolic blood pressure (137 +/- 9 to 116 +/- 8, and 159 +/- 8 to 126 +/- 4 mmHg, respectively) and proteinuria (62 +/- 2 to 37 +/- 3, and 132 +/- 8 to 87 +/- 5 mg/day, respectively). Moreover, pharmacological RAS inhibition reduced angiotensin (ANG) II and increased ANG 1-7 in the kidney and thereby may have delayed the progression of kidney disease. Furthermore, renal NO and EETs declined in the aging FHH rats but not in the control strain. The present results, especially the demonstration of exaggerated vascular responsiveness to ANG II, indicate that RAS may contribute to the development of hypertension and kidney disease in FHH rats. The activity of factors opposing the development of hypertension and protecting the kidney declined with age in this model. Therefore, therapeutic enhancement of this activity besides RAS inhibition could be attempted in the therapy of human hypertension associated with kidney disease.
机译:戴头巾的高血压(FHH)大鼠充当与肾小球超滤和蛋白尿症相关的自发性高血压的遗传模型。但是,有关FHH大鼠高血压和肾脏疾病自然过程的知识仍然是零碎的,其潜在的病理生理机制尚不清楚。在这项研究中,我们在动物的一生中追踪了成活率,血压(遥测),肾脏损害指数,肾素-血管紧张素(RAS)和一氧化氮(NO)系统的活性以及CYP450环氧酶产品( EETs)。与血压正常对照相比,在高血压前和高血压的FHH大鼠中血浆和肾RAS均未升高。但是,RAS抑制可显着降低收缩压(分别为137 +/- 9至116 +/- 8和159 +/- 8至126 +/- 4 mmHg)和蛋白尿(62 +/- 2至37 + / -3和132 +/- 8至87 +/- 5毫克/天)。此外,药理RAS抑制作用可降低肾脏中的血管紧张素(ANG)II和增加的ANG 1-7,从而可能延迟了肾脏疾病的进展。此外,在衰老的FHH大鼠中肾NO和EETs下降,但在对照品系中没有下降。目前的结果,特别是对ANG II的过度血管反应的证明,表明RAS可能有助于FHH大鼠高血压和肾脏疾病的发展。在该模型中,与高血压发展相反的因素的活性随年龄的增长而下降。因此,在与肾脏疾病有关的人类高血压的治疗中,除了RAS抑制作用外,还可以尝试增强这种活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号